Skip directly to site content Skip directly to page options Skip directly to A-Z link Skip directly to A-Z link Skip directly to A-Z link
Volume 31, Number 4—April 2025
Research Letter

Human Adenovirus B55 Infection in Patient without Recent Travel History, France

Menel Mohamedi1, Marion Dutkiewicz1, Clara Richard de Vesvrotte, Linda Feghoul, Abdeljalil Senhaji Rachik, Séverine Mercier-Delarue, Baptiste Hervier, Jérôme LeGoff, and Maud SalmonaComments to Author 
Author affiliation: Virology Department, AP-HP, Hôpital Saint-Louis, Paris, France (M. Mohamedi, M. Dutkiewicz, L. Feghoul, A.S. Rachik, S. Mercier-Delarue, J. LeGoff, M. Salmona); Department of Internal Medicine, AP-HP, Hôpital Saint-Louis, Paris (C.R. de Vesvrotte, B. Hervier); Inserm UMR-S 976, INSIGHT Team, University Paris Cité, Paris (L. Feghoul, J. LeGoff, M. Salmona); Inserm UMR-S 976, HIPI, Université Paris Cité, Paris (B. Hervier)

Main Article

Figure 2

Whole-genome phylogeny of human adenovirus B55 infection in patient without recent travel history, France. The phylogenetic tree was constructed by using the maximum-likelihood method in MAFFT (https://mafft.cbrc.jp). The strains from the patient reported in this study is designated as Patient_France_2024 (GenBank accession no. PQ723065). The statistical robustness of branches was estimated by 1,000 bootstraps. Only bootstrap values >80% are indicated. GenBank accession numbers, country, and year for isolates are provided. Scale bar indicates nucleotide substitutions per site.

Figure 2. Whole-genome phylogeny of human adenovirus B55 infection in patient without recent travel history, France. The phylogenetic tree was constructed by using the maximum-likelihood method in MAFFT (https://mafft.cbrc.jp). The strains from the patient reported in this study is designated as Patient_France_2024 (GenBank accession no. PQ723065). The statistical robustness of branches was estimated by 1,000 bootstraps. Only bootstrap values >80% are indicated. GenBank accession numbers, country, and year for isolates are provided. Scale bar indicates nucleotide substitutions per site.

Main Article

1These first authors contributed equally to this article.

Page created: February 07, 2025
Page updated: March 24, 2025
Page reviewed: March 24, 2025
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.
file_external